Recombinant hepatitis B vaccine (Hansenula Polymorpha, Hualan Biological Bacterin)

重组乙型肝炎疫苗（汉逊酵母，华兰生物疫苗）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant hepatitis B vaccine (Hansenula Polymorpha, Hualan Biological Bacterin)

Drug Alias Name重组乙型肝炎疫苗（华兰生物工程股份有限公司）Recombinant Hepatitis B vaccine (Hansenula Polymorpha, Hualan Biological Bacterin)Hepatitis B vaccine recombinant (Hualan Biological Engineering)

ClassificationVaccines > National Immunization Program > Immunization program vaccine(Class I)Vaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis B

Global Approved IndicationsHepatitis B

Approved Indications in ChinaHepatitis B

Original Approved Country/TerritoryMainland China

Original Approved Date2010/06/02

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesHualan Biological Bacterin Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHualan Biological Bacterin Co Ltd

Inactive CompaniesHualan Biological Engineering Inc

Active IndicationsHepatitis B

Inactive IndicationsN/A

Other Information

ATC CodeJ07BC01